ELIZABETH MENSAH: Open Payments
NPI 1558065318 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 12 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $43 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $93 |
| Neurocrine BioSciences, Inc. | 2 | $79 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| Alkermes, Inc. | 1 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
Products named: COBENFY, INGREZZA, ARISTADA, SPRAVATO, INVEGA SUSTENNA, REXULTI, ABILIFY ASIMTUFII.
Industry payments across AR — which companies pay providers there.
